Treatment Outcomes of Multidrug‑Resistant Tuberculosis Patients in East Java, Indonesia: A Retrospective Cohort Analysis
Background: The drug regimen for the treatment of multidrug-resistant tuberculosis (MDR-TB) has lower potency, is more costly, and has a greater risk of adverse effects than first‑line anti‑TB drugs. We aimed to compare the treatment outcomes of patients using standard shorter regimen (STR regimen...
Saved in:
Main Authors: | Indarti, Hardini Tri, Kristin, Erna, Soedarsono, Soedarsono, Endarti, Dwi |
---|---|
Format: | Article PeerReviewed |
Language: | English |
Published: |
Wolters Kluwer
2022
|
Subjects: | |
Online Access: | https://repository.ugm.ac.id/283429/1/220.pdf https://repository.ugm.ac.id/283429/ https://journals.lww.com/ijmy/fulltext/2022/11030/treatment_outcomes_of_multidrug_resistant.6.aspx |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Universitas Gadjah Mada |
Language: | English |
Similar Items
-
Comparison of Chest X-Ray Findings Between Primary and Secondary Multidrug Resistant Pulmonary Tuberculosis
by: Ricky Septafianty, Ricky, et al. -
Delay in treatment initiation and treatment outcomes among adult patients with multidrug-resistant tuberculosis at Yangon Regional Tuberculosis Centre, Myanmar: A retrospective study
by: Ye Minn Htun, et al.
Published: (2019) -
Whole-genome sequencing analysis of multidrug-resistant Mycobacterium tuberculosis from Java, Indonesia
by: Tryna Tania, et al.
Published: (2020) -
The Battle Continues: An Interpretative Phenomenological Analysis of the Experiences of Multidrug-Resistant Tuberculosis (MDR-TB) Patients
by: Teh, Lota A, et al.
Published: (2018) -
A Woman with Tuberculosis Multidrug Resistance and QTc Prolongation Repetitive Interval: A Case Report
by: Tutik Kusmiati, Tutik, et al.